| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Alterity Therapeutics Limited (NASDAQ: ATHE)
ATHE Technical Analysis
3
| As on 24th Apr 2025 ATHE STOCK Price closed @ 3.54 and we RECOMMEND Buy for LONG-TERM with Stoploss of 1.96 & Buy for SHORT-TERM with Stoploss of 2.44 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ATHESTOCK Price
| Open | 3.41 | Change | Price | % |
| High | 3.54 | 1 Day | 0.03 | 0.85 |
| Low | 3.41 | 1 Week | 0.33 | 10.28 |
| Close | 3.54 | 1 Month | -0.29 | -7.57 |
| Volume | 2758 | 1 Year | 1.16 | 48.74 |
| 52 Week High 4.99 | 52 Week Low 1.05 | ||||
NASDAQ USA Most Active Stocks
| AMRS | 0.14 | 100.00% |
| GNLN | 0.02 | -92.00% |
| OMEX | 0.85 | 97.67% |
| NVDA | 106.43 | 3.62% |
| CNEY | 0.14 | 7.69% |
| OPEN | 0.78 | -7.14% |
| LMDX | 0.02 | 0.00% |
| INTC | 21.49 | 4.37% |
| AKTS | 0.04 | 0.00% |
| TSLA | 259.51 | 3.50% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| ATHE Daily Charts |
ATHE Intraday Charts |
Whats New @ Bazaartrend |
ATHE Free Analysis |
|
|
ATHE Important Levels Intraday
| RESISTANCE | 3.79 |
| RESISTANCE | 3.71 |
| RESISTANCE | 3.66 |
| RESISTANCE | 3.61 |
| SUPPORT | 3.47 |
| SUPPORT | 3.42 |
| SUPPORT | 3.37 |
| SUPPORT | 3.29 |
ATHE Forecast April 2025
| 4th UP Forecast | 10.96 |
| 3rd UP Forecast | 8.58 |
| 2nd UP Forecast | 7.11 |
| 1st UP Forecast | 5.64 |
| 1st DOWN Forecast | 1.44 |
| 2nd DOWN Forecast | -0.03 |
| 3rd DOWN Forecast | -1.5 |
| 4th DOWN Forecast | -3.88 |
ATHE Weekly Forecast
| 4th UP Forecast | 4.14 |
| 3rd UP Forecast | 3.95 |
| 2nd UP Forecast | 3.83 |
| 1st UP Forecast | 3.71 |
| 1st DOWN Forecast | 3.37 |
| 2nd DOWN Forecast | 3.25 |
| 3rd DOWN Forecast | 3.13 |
| 4th DOWN Forecast | 2.94 |
ATHE Forecast2025
| 4th UP Forecast | 12.92 |
| 3rd UP Forecast | 9.91 |
| 2nd UP Forecast | 8.05 |
| 1st UP Forecast | 6.19 |
| 1st DOWN Forecast | 0.89 |
| 2nd DOWN Forecast | -0.97 |
| 3rd DOWN Forecast | -2.83 |
| 4th DOWN Forecast | -5.84 |
Alterity Therapeutics Limited ( NASDAQ USA Symbol : ATHE )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ATHE Business Profile
Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also developing PBT2 that has completed Phase IIa clinical trial to treat Alzheimer's disease. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is headquartered in Melbourne, Australia. Address: 460 Bourke Street, Melbourne, VIC, Australia, 3000
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service